|Articles|November 1, 2006

Pharmacy Times

  • Volume 0
  • 0

DEA MOVES TO HALT INTERNET PILL FRAUD

The US Drug Enforcement Administration(DEA) is moving to close downwhat federal officials are calling a "genericpill fraud scheme" involving the sale ofbogus Canadian generic drugs over theInternet. Those charges were leveled atthe operators of Norcross, Ga-based Hi-Tech Pharmaceuticals, an outfit that theDEA says produced a number of prescriptionand controlled substances underunsafe conditions in the Caribbean, thenmarketed on the Internet as low-costgeneric drugs from Canada.

Hi-Tech allegedly produced ~24 differentknockoff medicines that were marketedthrough spam advertisements on theInternet as authentic generic versions ofthose drugs being imported from Canada.According to the DEA, the drugs includedsteroids such as oxymetholone andstanozolol, along with unapproved versionsof controlled drugs such as Ambien(zolpidem tartrate),Valium (diazepam), andXanax (alprazolam). The defendants alsomanufactured versions of prescriptiondrugs such as Viagra (sildenafil citrate),Cialis (tadalafil), Lipitor (atorvastatin calcium),and Vioxx (rofecoxib).

Between 2002 and 2004, the companyallegedly ordered enough active ingredientsto manufacture millions of pills, manyof which were then shipped into theUnited States to various wholesalers, aswell as to individuals who purchased thedrugs after receiving Internet spam.

Articles in this issue

almost 19 years ago

Cold Sore Outbreak?

almost 19 years ago

compounding HOTLINE

almost 19 years ago

can you READ these Rxs?

almost 19 years ago

Time to Share Accountability

almost 19 years ago

Labeling in Failure-to-Warn Case

almost 19 years ago

Ohio Prosecutors Fight Rx Abuse

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME